Recommendations of the European Working Group for Adult ALL

B 2011

Recommendations of the European Working Group for Adult ALL

GÖKBUGET, N., R. BASSAN, H. DOMBRET, Michael DOUBEK, A.K. FIELDING et. al.

Základní údaje

Originální název

Recommendations of the European Working Group for Adult ALL

Autoři

GÖKBUGET, N. (276 Německo, garant), R. BASSAN (276 Německo), H. DOMBRET (276 Německo), Michael DOUBEK (203 Česká republika, domácí), A.K. FIELDING (276 Německo), R. FOÀ (276 Německo), S. GIEBEL (276 Německo), D. HOELZER (276 Německo), G. MARTINELLI (276 Německo), G. MELONI (276 Německo), A.D. MOICEAN (276 Německo), O. OTTMANN (276 Německo), P.P. PICCALUGA (276 Německo), J.M. RIBERA (276 Německo), P. ROUSSELOT (276 Německo) a J. WALEWSKI (276 Německo)

Vydání

1st edition. Bremen – London – Boston, 208 s. Unimed Science, 2011

Nakladatel

UNI-MED Verlag AG

Další údaje

Jazyk

angličtina

Typ výsledku

Odborná kniha

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Německo

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/11:00055375

Organizační jednotka

Lékařská fakulta

ISBN

978-1-84815-178-9

Klíčová slova anglicky

Acute lymphoblastic leukemia; targeted therapy; optimisation of chemotherapy

Změněno: 28. 8. 2012 13:03, Mgr. Michal Petr

Anotace

V originále

Acute lymphoblastic leukemia (ALL) is a malignant disease of lymphatic cells in the bone marrow or other organs of the lymphoid system with a number of unique features. Cure rates were improved in the past decades first in children and later in adults from less than 10% to 40-50% and even >50% in distinct subgroups. Important progress was also achieved in basic research, particularly in molecular genetics. The progress in terms of diagnosis and treatment of ALL has stemmed mainly from systematic clinical research by a number of cooperative study groups. It is based on optimisation of chemotherapy, stem cell transplantation, supportive care integrated in risk adapted treatment strategies and more recently complemented by approaches for targeted therapy. The book gives an overview on the current strategies for management of adult ALL including approaches to rare entities and specific situations. It represents the result of a structured consensus process conducted by the members of the European Working Group for Adult ALL.

Přiložené soubory

recommendationsALL.pdf

Požádat o autorskou verzi souboru

Citovat

GÖKBUGET, N., R. BASSAN, H. DOMBRET, Michael DOUBEK, A.K. FIELDING, R. FOÀ, S. GIEBEL, D. HOELZER, G. MARTINELLI, G. MELONI, A.D. MOICEAN, O. OTTMANN, P.P. PICCALUGA, J.M. RIBERA, P. ROUSSELOT a J. WALEWSKI. Recommendations of the European Working Group for Adult ALL. 1st edition. Bremen – London – Boston: UNI-MED Verlag AG, 2011, 208 s. Unimed Science. ISBN 978-1-84815-178-9.

@book{969557,
   author = {Gökbuget, N. and Bassan, R. and Dombret, H. and Doubek, Michael and Fielding, A.K. and Foà, R. and Giebel, S. and Hoelzer, D. and Martinelli, G. and Meloni, G. and Moicean, A.D. and Ottmann, O. and Piccaluga, P.P. and Ribera, J.M. and Rousselot, P. and Walewski, J.},
   address = {Bremen – London – Boston},
   edition = {1st edition},
   keywords = {Acute lymphoblastic leukemia; targeted therapy; optimisation of chemotherapy},
   language = {eng},
   location = {Bremen – London – Boston},
   isbn = {978-1-84815-178-9},
   publisher = {UNI-MED Verlag AG},
   title = {Recommendations of the European Working Group for Adult ALL},
   year = {2011}
}

TY  - BOOK
ID  - 969557
AU  - Gökbuget, N. - Bassan, R. - Dombret, H. - Doubek, Michael - Fielding, A.K. - Foà, R. - Giebel, S. - Hoelzer, D. - Martinelli, G. - Meloni, G. - Moicean, A.D. - Ottmann, O. - Piccaluga, P.P. - Ribera, J.M. - Rousselot, P. - Walewski, J.
PY  - 2011
TI  - Recommendations of the European Working Group for Adult ALL
VL  - Unimed Science
PB  - UNI-MED Verlag AG
CY  - Bremen – London – Boston
SN  - 9781848151789
KW  - Acute lymphoblastic leukemia
KW  - targeted therapy
KW  - optimisation of chemotherapy
N2  - Acute lymphoblastic leukemia (ALL) is a malignant disease of lymphatic cells in the bone marrow or other organs of the lymphoid system with a number of unique features. Cure rates were improved in the past decades first in children and later in adults from less than 10% to 40-50% and even >50% in distinct subgroups. Important progress was also achieved in basic research, particularly in molecular genetics. The progress in terms of diagnosis and treatment of ALL has stemmed mainly from systematic clinical research by a number of cooperative study groups. It is based on optimisation of chemotherapy, stem cell transplantation, supportive care integrated in risk adapted treatment strategies and more recently complemented by approaches for targeted therapy. The book gives an overview on the current strategies for management of adult ALL including approaches to rare entities and specific situations. It represents the result of a structured consensus process conducted by the members of the European Working Group for Adult ALL.
ER  -

GÖKBUGET, N., R. BASSAN, H. DOMBRET, Michael DOUBEK, A.K. FIELDING, R. FOÀ, S. GIEBEL, D. HOELZER, G. MARTINELLI, G. MELONI, A.D. MOICEAN, O. OTTMANN, P.P. PICCALUGA, J.M. RIBERA, P. ROUSSELOT a J. WALEWSKI. \textit{Recommendations of the European Working Group for Adult ALL}. 1st edition. Bremen – London – Boston: UNI-MED Verlag AG, 2011, 208 s. Unimed Science. ISBN~978-1-84815-178-9.

Přehled o publikaci